1 – 63 of 63
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Evaluating person-centered care in neurological outpatient care : a mixed-methods content validity study
(
- Contribution to journal › Article
-
Mark
Prevalence and disease disability in immigrants with multiple sclerosis in Malmö, southern Sweden
(
- Contribution to journal › Article
-
Mark
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden : An observational cohort study
(
- Contribution to journal › Article
-
Mark
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
(
- Contribution to journal › Article
- 2023
-
Mark
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
(
- Contribution to journal › Article
-
Mark
Varicella-zoster virus vasculopathy in a patient with multiple sclerosis receiving natalizumab
(
- Contribution to journal › Article
-
Mark
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
2023) In Journal of Neurology, Neurosurgery and Psychiatry(
- Contribution to journal › Article
- 2022
-
Mark
Mapping of neuroinflammation-induced hypoxia in the spinal cord using optoacoustic imaging
(
- Contribution to journal › Article
-
Mark
Editorial : Genotype–phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis : A presymptomatic case–control study
(
- Contribution to journal › Article
-
Mark
Systemic inflammation and risk of multiple sclerosis – A presymptomatic case-control study
(
- Contribution to journal › Article
-
Mark
High-resolution HLA class II sequencing of Swedish multiple sclerosis patients
(
- Contribution to journal › Article
- 2021
-
Mark
Leptin levels are associated with multiple sclerosis risk
(
- Contribution to journal › Article
-
Mark
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study
(
- Contribution to journal › Article
-
Mark
Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients
(
- Contribution to journal › Article
-
Mark
Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use : case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation
(
- Contribution to journal › Article
-
Mark
Increased intestinal permeability in primary Sjögren's syndrome and multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis
(
- Contribution to journal › Article
-
Mark
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
(
- Contribution to journal › Scientific review
-
Mark
Multiple sclerosis among first- and second-generation immigrant groups in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Benefit–risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis
(
- Contribution to journal › Article
-
Mark
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
(
- Contribution to journal › Article
- 2018
-
Mark
Cognitive functioning following one-year natalizumab treatment : A non-randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Male factor infertility and risk of multiple sclerosis : A register-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis : Recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
(
- Contribution to journal › Article
-
Mark
Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis
(
- Contribution to journal › Article
-
Mark
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
(
- Contribution to journal › Article
- 2016
-
Mark
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo
(
- Contribution to journal › Article
- 2014
-
Mark
CD1d restricted NKT cells in regulation of pathogenic autoimmunity
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy.
2012) In Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 44(1). p.87-90(
- Contribution to journal › Article
-
Mark
Cost of multiple sclerosis in the Czech Republic: The COMS study
(
- Contribution to journal › Article
- 2011
-
Mark
MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
(
- Contribution to journal › Article
- 2010
-
Mark
Anticipation of age at onset in multiple sclerosis: methodologic pitfalls
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
(
- Contribution to journal › Article
-
Mark
International Development of the Unidimensional Fatigue Impact Scale (U-FIS)
(
- Contribution to journal › Article
-
Mark
International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)
(
- Contribution to journal › Article
- 2009
-
Mark
Distribution and Function of Cannabinoid Receptors 1 and 2 in the Rat, Monkey and Human Bladder
(
- Contribution to journal › Article
-
Mark
Engagement in occupations in persons with Multiple Sclerosis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Constantly Changing Lives: Experiences of People With Multiple Sclerosis
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
(
- Contribution to journal › Article
- 2008
-
Mark
Diagnostic, prognostic and management aspects of different types of multiple sclerosis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Implementation of a Protein Profiling Platform Developed as an Academic-Pharmaceutical Industry Collaborative Effort
(
- Contribution to journal › Article
-
Mark
Transglutaminase and peptidylarginine deiminase in the pathogenesis of autoimmune diseases
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Article
- 2006
-
Mark
Deficient Fas expression by CD4+CCR5+T cells in multiple sclerosis
(
- Contribution to journal › Article
-
Mark
The complexity of daily occupations in multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
The Role of Matrix Metalloproteinases in Leukocyte Transmigration in Murine Experimental Autoimmune Encephalomyelitis
2006) In Journal of Experimental Medicine(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
The meaning of fatigue for women with multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE
(
- Contribution to journal › Article
-
Mark
Multiple Sclerosis: Studies of the Interferon system and search for infectious agents
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.
(
- Contribution to journal › Article
- 2003
-
Mark
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
(
- Contribution to journal › Article
- 2002
-
Mark
International consensus statement on the use of disease-modifying agents in multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis
(
- Contribution to journal › Article
- 2001
-
Mark
The H2-Ab gene influences the severity of experimental allergic encephalomyelitis induced by proteolipoprotein peptide 103-116
(
- Contribution to journal › Article
- 2000
-
Mark
Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions
(
- Contribution to journal › Article
- 1998
-
Mark
Cyclic nucleotide signalling systems in vascular smooth muscle cells and immune system cells with special reference to phosphodiesterases PDE3 and PDE4
1998)(
- Thesis › Doctoral thesis (compilation)
- 1993
-
Mark
Reduction of MS-related scotomata by a new class of potassium channel blockers from ruta graveolens
(
- Contribution to journal › Article